Cancer Services : [322] Collection home page

Browse
in this collection
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 322
Issue DateTitleAuthor(s)
2019-02Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS.Yannakou, Costas; Prince, Miles; Gregory, Gareth; Dickinson, Michael; Wong, Jonathon; Bomberry, Piers; Corboy, Greg; Kats, Lev; Crozier, Tim; Kumar, Beena; Opat, Stephen; Short, Jake 
2019-11Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.Prince, Miles; Attal, Michel; Richardson, Paul; Rajkumar, S.Vincent; San-Miguel, Jesus; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios; Huang, Jeffrey; Minarik, Jiri; Cavo, Michele; Macé, Sandrine; Corzo, Kathryn; Campana, Frank; Le-Guennec, Solenn; Dubin, Franck; Anderson, Kenneth; study group, ICARIA-MM 
2019-10Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.Prince, Miles; Gao, Crystal; McCormack, Christopher; van der Weyden, Carrie; Goh, Michelle; Campbell, Belinda; Twigger, Robert; Buelens, Odette; Harrison, Simon; Khoo, Christine; Lade, Stephen 
2019-11Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors.Prince, Miles; Loch-Wilkinson, Anna; Beath, Kenneth; Magnusson, Mark; Cooter, Rodney; Shaw, Karen; French, James; Vickery, Karen; Deva, Anand 
2019-01FDG-PET/CT findings, the vital clue to rare diagnosis of herpes simplex virus lymphadenitis simulating Richter transformation.Prince, Miles; Douglas, Abby; Atarod, Mohammad 
2019-10A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients.Prince, Miles; Brooker, Joanne; Julian, John; Millar, Jeremy; Kenealy, Melita; Herbert, Kirsten; Graham, Annette; Smith, Robin; Kissane, David; Taylor, Karen; Frydenberg, Mark; Porter, Ian; Fletcher, Jane; Haines, Ian; Burney, Sue 
2019-05Molecular drivers of breast implant-associated anaplastic large cell lymphoma.Prince, Miles; Blombery, Piers; Thompson, Ella 
2019-05The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants.Prince, Miles; Magnusson, Mark; Beath, Kenneth; Cooter, Rodney; Locke, Michelle; Elder, Elisabeth; Deva, Anand 
2019-09Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.Prince, Miles; Horvath, Noemi; Spencer, Andrew; Kenealy, Melita; Joshua, Douglas; Campbell, Philip; Lee, Je; Hou, Jian; Qiu, Lugui; Kalff, Anna; Khong, Tiffany; Londhe, Anil; Siggins, Sarah; van Kooten Losio, Maximiliano; Eisbacher, Michael 
2019-11Lack of durable remission with conventional-dose total skin electron therapy for the management of Sezary syndrome and multiple relapsed mycosis fungoides.Prince, Miles; Campbell, Belinda; Ryan, Gail; McCormack, Christopher; Tangas, Eleanor; Bressel, Mathias; Twigger, Robert; Buelens, Odette; van der Weyden, Carrie 
2019-07The use of optimal treatment for DLBCL is improving in all age groups and is a key factor in overall survival, but non-clinical factors influence treatment.Prince, Miles; Doo, Nicole; White, Victoria; Martin, Kara; Bassett, Julie; Harrison, Simon; Jefford, Michael; Winship, Ingrid; Millar, Jeremy; Milne, Roger; Seymour, John; Giles, Graham 
2020-12A phase I study to evaluate the safety and pharmacokinetic profiles of CB-5339 in participants with relapsed/refractory acute myeloid leukemia or relapsed/refractory intermediate or high-risk myelodysplastic syndrome.Yannakou, Costas; Benajiba, Lena; Caraway, Hetty; Hamad, Nada; Stein, Eytan; Burroughs, Amy; Haris, Scott; Lane, Hayley; Ngyuen, Dorothy; Stuart, Monic; Vargas, Jesse; Puissant, Alexandre; Stegmaier, Kimberly; Dinardo, Courtney 
2020-06A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History.Yellapu, Bhargavi; Prall, Owen; McEvoy, Christopher; Byrne, David; Iravani, Amir; Browning, Judy; Yew, David; O'Haire, Sophie; Smith, Kortnye; Luen, Stephen; Mitchell, Paul; Desai, Jayesh; Fox, Stephen; Fellowes, Andrew; Xu, Huiling 
2020-11A novel application of [18F] fluorothymidine-PET ([18F]FLT-PET) in clinical practice to quantify regional bone marrow function in a patient with treatment-Induced cytopenias and to guide "marrow-sparing" radiotherapy.Prince, Miles; Campbell, Belinda; Hofman, Michael 
2020-02A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.Prince, Miles; Maqbool, M. Gohar; Tam, Constantine; Morison, Ian; Simpson, David; Mollee, Peter; Schneider, Hans; Chan, Henry; Juneja, Surrender; Harvey, Yasmin; Nath, Lakshmi; Hissaria, Pravin; Wordsworth, Helen; Opat, Stephen; Talaulikar, Dipti 
2020-12707 Survival outcomes for plasmablastic lymphoma: an international, multicentre study by the Australasian Lymphoma Alliance.Yannakou, Costas; Polizzotto, Mark; Cwynarski, Kate; Burton, Cathy; Jiamsakul, Awachana; Bower, Mark; Kuruvilla, John; Montoto, Silvia; McKay, Pam; Osborne, Wendy; Miliken, Sam; Linton, Kim; Manos, Kate; Kassam, Shireen; Doo, Nicole; Watson, Anne-Marie; Fedele, Pasquale; Hunt, Stewart; Renshaw, Hanna; Thakrar, Nisha; Smith, Alexandra; Painter, Daniel; Maxwell, Alice; Liu, Qin; Dhairyawan, Rageshri; Ferguson, Graeme; Pickard, Keir; Hamad, Nada 
2020-07Prolonged lymphopenia and infection risk is mitigated by antimicrobial prophylaxis in patients with indolent non-Hodgkin Lymphoma (iNHL) treated with bendamustine +/- anti-CD20 antibody: the Australian Lymphoma Alliance experience.Yannakou, Costas; Manos, Kate; Lasica, Masa; Grigg, Andrew; Di Ciaccio, Pietro; Wong, Jonathan; Sekaran, Usha; Wight, Joel; Goh, Zhong; Jina, Hayden; Butler, Llewyn; Hamad, Nada; Gregory, Gareth; Gangatharan, Shane; Cochrane, Tara; Piper, Kristen; Churilov, Leonid; Hawkes, Eliza 
2020-10Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukaemia and follicular lymphoma.Prince, Miles; Tam, Constantine; Quach, Hang; Nicol, Andrew; Badoux, Xavier; Rose, Hannah; Leahy, Michael; Wickham, Nicholas; Patil, Sushrut; Huang, Jane; Prathikanti, Radha; Cohen, Aileen; Elstrom, Rebecca; Reed, William; Schneider, Jingjing; Flinn, Ian 
2020-10T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.Prince, Miles; Ghione, Paola; Faruque, Promie; Mehta-Shah, Neha; Seshan, Venkatraman; Ozkaya, Neval; Bhaskar, Shakthi; Yeung, James; Spinner, Michael; Lunning, Matthew; Inghirami, Giorgio; Moskowitz, Alison; Galasso, Natasha; Ganesan, Nivetha; van der Weyden, Carrie; Ruan, Jia; Trotmani, Judith; Advani, Ranjana; Dogan, Ahmet; Horwitz, Steven 
2020-05Safety and activity of the once daily selective Bruton Tyrosine Kinase (BTK) inhibitor TG-1701 in patients with chronic lymphocytic leukaemia (CLL) and lymphoma.Yannakou, Costas; Chan, Cheah; Wickham, Nicholas; Lewis, Katharine; Hui, Chi-Hung; Tang, Pek; Turpuseema, Tejasvi; Miskin, Hari; Tang, Jian-Ping; Normant, Emmanuel; Ricart, Alejandro; Tam, Constantine 
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 322